Norio Motohashi
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Evaluation for the Efficacy of Exon-Skipping Therapy Using In Vivo Assessment of Skeletal Muscle Function and Fragility.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 01, 2025
Exon-Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 28, 2025
Polyplex Nanomicelle-Mediated Pgc-1α4 mRNA Delivery Via Hydrodynamic Limb Vein Injection Enhances Damage Resistance in Duchenne Muscular Dystrophy Mice.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 02, 2024
Prostaglandin E2 receptor EP2 is indispensable for maintenance of skeletal muscle stem cells.
Journal: Stem cells (Dayton, Ohio)
Published: April 20, 2024
Cancer-specific epigenome identifies oncogenic hijacking by nuclear factor I family proteins for medulloblastoma progression.
Journal: Developmental cell
Published: November 02, 2023
Characterization of CD90/Thy-1 as a crucial molecular signature for myogenic differentiation in human urine-derived cells through single-cell RNA sequencing.
Journal: Scientific reports
Published: June 16, 2023
Techniques for Injury, Cell Transplantation, and Histological Analysis in Skeletal Muscle.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 30, 2023
High-intensity interval training in the form of isometric contraction improves fatigue resistance in dystrophin-deficient muscle.
Journal: The Journal of physiology
Published: February 13, 2023
Systemic administration of the antisense oligonucleotide NS-089/NCNP-02 for skipping of exon 44 in patients with Duchenne muscular dystrophy: Study protocol for a phase I/II clinical trial.
Journal: Neuropsychopharmacology reports
Published: December 22, 2022
Exon 44 skipping in Duchenne muscular dystrophy: NS-089/NCNP-02, a dual-targeting antisense oligonucleotide.
Journal: Molecular therapy. Nucleic acids
Published: December 10, 2022
Quantitative Evaluation of Exon Skipping in Urine-Derived Cells for Duchenne Muscular Dystrophy.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 18, 2022
Last Updated: 09/26/2026